A consortium of news outlets is questioning the safety of Haemonetics (NYSE:HAE)
blood-collection devices, claiming that particles have been detected in donors whose plasma was extracted by the machines.
According to a report in the Miami Herald, whistleblower documents indicate that more than 150 Haemonetics customer reports have been made regarding the presence of particles by plasma collection centers and heathcare facilities in the U.S. between 2005 and 2019.
Apheresis devices are used to separate plasma from blood and then return it to the donor. Governments around the world are encouraging people who have survived COVID-19 to donate plasma to be used in treating other patients.
Get the full story on our sister site, MassDevice.
